These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 35395767)
1. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma. Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767 [TBL] [Abstract][Full Text] [Related]
2. RBM33 is a unique m Yu F; Zhu AC; Liu S; Gao B; Wang Y; Khudaverdyan N; Yu C; Wu Q; Jiang Y; Song J; Jin L; He C; Qian Z Mol Cell; 2023 Jun; 83(12):2003-2019.e6. PubMed ID: 37257451 [TBL] [Abstract][Full Text] [Related]
3. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9. Li Y; Yan B; Wang X; Li Q; Kan X; Wang J; Sun Y; Wang P; Tian L; Liu M J Cell Mol Med; 2022 Jan; 26(2):385-398. PubMed ID: 34850551 [TBL] [Abstract][Full Text] [Related]
4. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928 [TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
6. ALKBH5 activates FAK signaling through m6A demethylation in Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222 [No Abstract] [Full Text] [Related]
7. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner. Yang Z; Cai Z; Yang C; Luo Z; Bao X EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460 [TBL] [Abstract][Full Text] [Related]
8. ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages. Hua X; Xu Q; Wu R; Sun W; Gu Y; Zhu S; Liu X; Lv T; Song Y J Exp Clin Cancer Res; 2024 Jun; 43(1):164. PubMed ID: 38872221 [TBL] [Abstract][Full Text] [Related]
9. RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m Ye J; Chen X; Jiang X; Dong Z; Hu S; Xiao M J Clin Lab Anal; 2022 Jul; 36(7):e24514. PubMed ID: 35689537 [TBL] [Abstract][Full Text] [Related]
10. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989 [TBL] [Abstract][Full Text] [Related]
11. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466 [TBL] [Abstract][Full Text] [Related]
12. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239 [TBL] [Abstract][Full Text] [Related]
13. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway. Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154 [TBL] [Abstract][Full Text] [Related]
14. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11. Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004 [TBL] [Abstract][Full Text] [Related]
15. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer. Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959 [TBL] [Abstract][Full Text] [Related]
16. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma. Zhen L; Pan W Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046 [TBL] [Abstract][Full Text] [Related]
17. ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease via Innate Immune Response. Chen G; Zhao Q; Yuan B; Wang B; Zhang Y; Li Z; Du S; Zeng Z Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):491-501. PubMed ID: 34044094 [TBL] [Abstract][Full Text] [Related]
18. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway. Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma. Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343 [TBL] [Abstract][Full Text] [Related]
20. m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency. Li G; Luo R; Zhang W; He S; Wang B; Liang H; Song Y; Ke W; Shi Y; Feng X; Zhao K; Wu X; Zhang Y; Wang K; Yang C Clin Transl Med; 2022 Mar; 12(3):e765. PubMed ID: 35340126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]